Inhibition of poly (ADP-ribose) synthetase prevents the neurological development of experimental allergic encephalomyelitis

Keyphrases

• Poly(ADP-ribose) Synthetase 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Neurological Development 100%
• Peroxynitrite 33%
• 3-aminobenzamide 33%
• Autoimmune Disease 16%
• Etiology 16%
• Disease Severity 16%
• Amino 16%
• Cell-mediated 16%
• Cytotoxicity 16%
• Neurological Diseases 16%
• Disease Course 16%
• Drug-treated 16%
• Disease Etiology 16%
• Disease Development 16%
• Disease Incidence 16%
• Nervous System Diseases 16%
• 1,2-benzopyrone 16%
• Once-daily 16%
• Multiple Sclerosis 16%
• Lewis Rats 16%
• Post Inoculation 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Synthetase 100%
• Poly(adenosine Diphosphate Ribose) 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Disease 66%
• Peroxynitrite 33%
• 3 Aminobenzamide 33%
• Autoimmune Disease 16%
• Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor 16%
• Neurologic Disease 16%
• Disease Course 16%
• Coumarin 16%
• Multiple Sclerosis 16%
• Lewis Rat 16%
• Cytotoxicity 16%

Neuroscience

• Poly ADP Ribose Polymerase 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Central Nervous System 16%
• Cytotoxicity 16%
• Nervous System Disorder 16%
• Coumarin 16%
• PARP Inhibitor 16%
• Multiple Sclerosis 16%
• Autoimmune Disease 16%